Biotech
Brain Drain
Synchron Pauses Trials of Its Brain Implant Due to Performance Issues
After its latest device struggled to perform, brain-computer interface startup Synchon halted clinical trials. The company says it will upgrade the implant’s hardware and is at work on a new device.
Getting Defensive
A Startup Wants to Fight AI Bioweapons With AI
Not Brain Surg—Oh
An AI Agent Injected Drugs Into a Live Mouse’s Brain
Learning Curve
Anthropic Says It Will Revolutionize Biology—Some Day
Uncanny Valley
Inside the Exclusive Nathan Fielder Interview
Not Going Viral
